Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
28968 | 160 | 24.5 | 43% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1875 | 5483 | SYNCOPE//VASOVAGAL SYNCOPE//NEUROCARDIOGENIC SYNCOPE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | L THREO 3 4 DIHYDROXYPHENYLSERINE | Author keyword | 15 | 82% | 6% | 9 |
2 | 3 4 DIHYDROXYPHENYLSERINE | Author keyword | 3 | 100% | 2% | 3 |
3 | AMINE PRECURSOR THERAPY | Author keyword | 3 | 100% | 2% | 3 |
4 | DIHYDROXYPHENYLSERINE | Author keyword | 2 | 67% | 1% | 2 |
5 | L ERYTHRO DOPS | Author keyword | 2 | 67% | 1% | 2 |
6 | L THREO DOPS | Author keyword | 2 | 40% | 3% | 4 |
7 | L DOPS | Author keyword | 2 | 36% | 3% | 4 |
8 | DOPAMINE BETA HYDROXYLASE DEFICIENCY | Author keyword | 2 | 43% | 2% | 3 |
9 | NOREPINEPHRINE DEFICIENCY | Author keyword | 1 | 100% | 1% | 2 |
10 | BETA HYDROXYHISTIDINE | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | L THREO 3 4 DIHYDROXYPHENYLSERINE L DOPS | 9 | 83% | 3% | 5 |
2 | DL THREO 3 4 DIHYDROXYPHENYLSERINE | 4 | 75% | 2% | 3 |
3 | L THREO 3 4 DIHYDROXYPHENYLSERINE | 3 | 26% | 6% | 9 |
4 | NOREPINEPHRINE PRECURSOR | 2 | 67% | 1% | 2 |
5 | L THREO DOPS | 1 | 31% | 3% | 4 |
6 | 3 4 DIHYDROXYPHENYLSERINE | 1 | 100% | 1% | 2 |
7 | DOPS | 1 | 40% | 1% | 2 |
8 | L THREO 3 4 DIHYDROXY PHENYLSERINE | 1 | 50% | 1% | 1 |
9 | NORADRENALINE PRECURSOR | 1 | 50% | 1% | 1 |
10 | PRECURSOR THERAPY | 0 | 20% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
L-dihydroxyphenylserine (L-DOPS): A norepinephrine prodrug | 2006 | 34 | 72 | 47% |
Result of long-term administration of L-threo-3,4-dihydroxyphenylserine in patients with pure akinesia as an early symptom of progressive supranuclear palsy | 1997 | 12 | 7 | 57% |
Dopamine beta-hydroxylase deficiency | 2006 | 14 | 13 | 54% |
DEVELOPMENT OF L-THREO-DOPS, A NOREPINEPHRINE PRECURSOR AMINO-ACID | 1994 | 4 | 32 | 88% |
THE TREATMENT OF ORTHOSTATIC HYPOTENSION WITH DIHYDROXYPHENYLSERINE | 1991 | 11 | 34 | 85% |
DOPAMINE BETA-HYDROXYLASE DEFICIENCY - A GENETIC DISORDER OF CARDIOVASCULAR REGULATION | 1991 | 69 | 26 | 23% |
Amine precursor therapy: Manipulation of brain amine activity with precursor amino acid | 1997 | 0 | 10 | 80% |
Postural instability in Parkinson's disease: the adrenergic hypothesis and the locus coeruleus | 2009 | 32 | 98 | 13% |
WHAT TO DO WHEN SINEMET FAILS .1. | 1984 | 9 | 4 | 50% |
NORADRENERGIC INFLUENCES ON DOPAMINERGIC FUNCTION AND THE PHARMACOLOGY OF DIHYDROXYPHENYLSERINE (DOPS) - IMPLICATION FOR PARKINSONS-DISEASE | 1985 | 11 | 14 | 36% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LIFE CHEM CELL PHYSIOL | 0 | 33% | 0.6% | 1 |
2 | MED CHUO KU | 0 | 33% | 0.6% | 1 |
3 | BASIC SPORTS MED | 0 | 13% | 0.6% | 1 |
4 | AUTONOM DYSFUNCT CLIN CLIN | 0 | 100% | 0.6% | 1 |
5 | PARKINSON NIJMEGEN PARC NEUROL 935 | 0 | 100% | 0.6% | 1 |
6 | PURIFICAT THER Y | 0 | 100% | 0.6% | 1 |
7 | VHIRLIVER UNIT INTERNAL MED | 0 | 100% | 0.6% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000250477 | POSTPRANDIAL HYPOTENSION//ORTHOSTATIC HYPOTENSION//AUTONOMIC FAILURE |
2 | 0.0000247839 | NEPICASTAT//COCAINE INDUCED PSYCHOSIS//DOPAMINE BETA HYDROXYLASE |
3 | 0.0000142143 | POSTURAL TACHYCARDIA SYNDROME//INAPPROPRIATE SINUS TACHYCARDIA//ORTHOSTATIC INTOLERANCE |
4 | 0.0000123649 | AROMATIC L AMINO ACID DECARBOXYLASE DEFICIENCY//AROMATIC L AMINO ACID DECARBOXYLASE//L DOPA DECARBOXYLASE |
5 | 0.0000097738 | DSP 4//DSP 4 N 2 CHLOROETHYL N ETHYL 2 BROMOBENZYLAMINE//XYLAMINE |
6 | 0.0000086536 | NEUROBEHAV NEUROBIOL NEUROPSYCHOL UNIT//TANDOSPIRONE CITRATE//3 MT |
7 | 0.0000083821 | BAROREFLEX FAILURE//NEUROVASCULAR COMPRESSION//CAROTID SINUS DENERVATION |
8 | 0.0000069178 | TERGURIDE//ERGOLINE//DOPAMINE D 2 AGONIST |
9 | 0.0000068179 | 2 3 4 5 TETRAHYDRO 1H 2 AZEPINE//2 3 4 5 TETRAHYDRO 1H 3 BENZAZEPINE//A RING CATECHOL |
10 | 0.0000065489 | ADRENERGIC DRUG//ISOCHROMAN 4 ONE//ETHANOL DIESEL FUEL ADDITIVE BLENDS |